TIDMPPIR TIDMPPIX
RNS Number : 0583D
ProPhotonix Limited
25 March 2014
ProPhotonix Limited
("ProPhotonix" or "the Company")
PRELIMINARY RESULTS FOR THE YEAR ENDED DECEMBER 31, 2013
ProPhotonix Limited (London Stock Exchange - AIM: PPIX and PPIR,
OTC: STKR), a designer and manufacturer of LED illumination systems
and laser diode modules with operations in Ireland and the United
Kingdom, today announces its unaudited preliminary results for the
year ended December 31, 2013.
Annual General Meeting
The Company will hold the Annual General Meeting of the
Shareholders on May 22, 2014 at
10:00 AM London Summer Time at the offices of K&L Gates LLP,
One New Change, London
EC4M 9AF. The Record date is set at April 7, 2014 for all
shareholders of record.
Financial Highlights
-- Revenue increased 12% to $15.6 million
-- Gross profit increased 38.6% to $6.0 million
-- Gross profit margin improved to 38.3%
-- Operating loss declined 62% to $1.2 million(1)
-- EBITDA loss declined 73.8% to $0.7 million(1)
-- Order bookings increased 17% to $17.6 million
-- Backlog at December 31, 2013 of $6.9 million grew 31%
-- Percentage revenue by market sectors: industrial 79%, medical
16%, and homeland security & defense 5%
-- Percentage revenue by geography: 52% Europe, 31% North America and 17% Rest of World
-- On June 20, 2013, the Company secured new loan financing with
net availability of $2.5 million through an existing lender to the
Company alongside a new lender.
-- On November 29, 2013, the Company entered into an amendment
to an existing revolving credit facility with Barclays Bank to
increase the existing credit facility from GBP650,000 ($1.1
million) to GBP1,400,000 ($2.3 million) and extending the duration
through the minimum of November 30, 2015.
-- Available borrowing capacity of $1.8 million from its loan facilities at December 31, 2013
(1) Includes $582,000 non-recurring charges
Tim Losik, President & CEO, Commented:
"During 2013 the Company experienced an improvement in business
activity with order bookings increasing 17% and the December 31,
2013 backlog up 31% from December 31, 2012; ending 2013 with a
book-to-bill ratio of 1.13 (2012:1.08). Of particular note are the
69% increase in bookings and 40% growth in revenue for the Americas
region which has been a significant regional growth focus. New
customer activity is a cornerstone for our growth and I am pleased
that we are continuously partnering with new customers. Revenue
from new customers accounted for $1.5 million of total revenue
growth across several market sectors, including: 3D Scanning for 3D
printing, Warehouse Robotics, Transport Container Monitoring and
Inspection, Medical Devices, UV curing, Aeronautics, and Industrial
Automation and Inspection.
"The revenue increase and cost reductions resulted in dramatic
improvement in operating performance and results. During the second
half of 2013, we realized significant improvement in operating
performance versus the first half 2013. Comparative improvements in
the second half 2013 versus first half 2013 (excluding the
restructuring and one-time charges of $582K in the first half)
include: Operating loss decreased 84% narrowing from ($517,000) to
($82,000) and EBITDA improved 164% from a loss of ($275,000) to a
positive EBITDA of $177,000. However, these improvements were
somewhat offset by non-cash changes in foreign currency exchange
rates and the resulting increase in material purchase prices, and
shifts in product mix; thereby depressing second half gross profit.
The improvements in second half operating income and EBITDA are
primarily the result of reductions in general and administrative
costs. We always seek to mitigate the effects of shifts in the
revenue mix, but predicting and controlling this can be
difficult."
Full Year 2013 Financial Results
Revenue for the year ended December 31, 2013 was $15.6 million,
an increase of 12% compared with $13.9 million in 2012. Gross
profit was $6.0 million compared to $4.3 million in 2012. Gross
profit margin increased to 38.3% from 31.0% in 2012 due to a shift
in product mix and an increase in volume.
Operating expenses, excluding intangible amortization charges,
totaled $7.0 million versus $7.3 million in 2012. Sales and
marketing expenses decreased 12% in 2013 over 2012, while general
and administrative and research and development expenses were
approximately flat over the same period and include restructuring
and one-time charges of $0.6 million taken in the first half of
2013. The operating loss was $1.2 million, as compared to a $3.1
million loss in 2012 and EBITDA was a loss of $0.7 million versus a
loss of $2.6 million in 2012. Net loss was $1.2 million compared to
the 2012 net loss of $2.9 million. Included in the operating
expenses, operating loss and EBITDA is approximately $0.6 million
of restructuring and one-time charges.
Strategy and Markets
ProPhotonix consists of two business units: an LED systems
manufacturing business based in Ireland (Cork), and a laser modules
production and laser diode distribution business located in the
United Kingdom (Hatfield Broad Oak). Corporate headquarters and the
North American sales activities are based in Salem, New Hampshire,
USA. The fundamental strategy of the Company is growth in revenue
through its existing customers, new customer activity, and new
product and market expansion. ProPhotonix's short-term strategy is
to reach sustained positive EBITDA, cash flow, and net income as
soon as possible. These goals will be accomplished through a
relentless focus on cost management and most importantly through
revenue growth.
ProPhotonix growth in the medium-term will be accomplished with
new customer wins with the conversion of development orders into
longer run orders, and also through expansion into new markets and
with new products. In addition to the few important areas where we
are currently focused, we will continuously evaluate additional
high growth opportunities by geography and business line.
ProPhotonix sells its products principally into three markets:
industrial (primarily machine vision illumination), medical, and
homeland security and defense. The Company foresees growth
opportunities in all three markets it serves which are briefly
described below:
Industrial (Machine Vision)
Within the industrial market, machine vision is the term used to
describe computerized analysis for controlling manufacturing
processes, for example automated inspection. In terms of quality
and speed, lighting is often a critical component in machine vision
and the Company manufactures both LED systems and lasers designed
specifically for this market. The recently enhanced 3D Pro Laser
line generators and improved LED line light family specifically
address this market.
Medical
The Company has experienced successes in the medical (including
dental) market and has gained a foothold in the market, supplying a
variety of applications, with current customers including the world
leader in stationary imaging equipment, a portable x-ray equipment
manufacturer, a dental imaging manufacturer and also a pioneer in
the manufacturing of devices offering eye tracking capability
utilizing ProPhotonix's custom infrared LED arrays. The Company
intends to broaden its product marketing effort in the medical
field since it offers significant long-term revenue growth
opportunities.
Homeland Security & Defense
LED systems, laser modules and laser diodes are used in a wide
variety of applications in the security and defense fields. The
Company currently supplies several defense sighting manufacturers
in the US and Europe, as well as leading manufacturers of Auto
Number Plate Recognition systems. This market offers significant
growth opportunities for ProPhotonix over the next several years
and the Company is currently marketing its laser and LED
capabilities to additional security and optical character
recognition systems companies in this market space.
Outlook
ProPhotonix begins 2014 with the strongest ever backlog at our
business units and with the necessary funding in place to move
forward in 2014. Included in 2013 bookings are about $800,000 of
customer bookings relating to new customer projects (non-recurring
engineering development), of which approximately $700,000 will be
recognized revenue in 2014. We expect to begin shipping trial and
production orders resulting from these projects during 2014 and
thereafter. These potential high volume OEM (custom) applications
include illuminators for the semiconductor, optical sorting,
endoscopy, and vascular imaging markets. We look forward to another
year of progress in 2014 and expect that first half revenue will be
in the range of $7.8 and $8.2 million.
Enquiries:
ProPhotonix Limited Tel: +1 603 870 8220
Tim Losik, President and CEO ir@prophotonix.com
N+1 Singer Tel: +44 (0) 207 496
Andrew Craig/ Ben Wright 3000
Nominated Adviser and Broker
About ProPhotonix
ProPhotonix Limited, headquartered in Salem, New Hampshire, is
an independent designer and manufacturer of diode-based laser
modules and LED systems for industry leading OEMs and medical
equipment companies. In addition, the Company distributes premium
diodes for Oclaro, Osram, QSI, Panasonic, and Sony. The Company
serves a wide range of markets including the machine vision,
industrial inspection, security, and medical markets. ProPhotonix
has offices and subsidiaries in the U.S., Ireland, U.K., and
Europe. For more information about ProPhotonix and its innovative
products, visit the Company's web site at www.prophotonix.com.
ProPhotonix Limited
Consolidated Statements of Operations and Comprehensive (Loss)
($ in thousands except share and per share data)
(unaudited)
Years Ended
December 31,
2013 2012
----------------- -----------------
Net Revenue $ 15,599 $ 13,904
Cost of Revenue (9,628) (9,597)
----------------- -----------------
Gross Profit 5,971 4,307
----------------- -----------------
Research & Development Expenses (941) (922)
Selling, General & Administrative Expenses (6,091) (6,403)
Amortization of Intangible Assets (120) (118)
----------------- -----------------
Operating Loss (1,181) (3,136)
----------------- -----------------
Other Income / (Expense), net 295 490
Warrant and Debt Acquisition expense (103) -
Interest Expense (237) (257)
----------------- -----------------
Loss Before Taxes (1,226) (2,903)
Tax Benefit 73 -
----------------- -----------------
Net Loss $ ( 1,153) $ ( 2,903)
Other comprehensive income (loss):
Foreign currency translation (368) (199)
-----------------
Total comprehensive loss $ ( 1,521) $ ( 3,102)
================= =================
Loss Per Share:
Basic and diluted net loss per share ($0.01) ($0.04)
Basic and diluted weighted average shares outstanding 80,496,977 76,059,457
------------------------------------------------------ ----------------- -----------------
PROPHOTONIX LIMITED
CONSOLIDATED BALANCE SHEETS
(unaudited)
($ in thousands except share and per share data)
December 31 2013 2012
Assets
Current assets:
Cash and cash equivalents $ 402 $ 1,278
Accounts receivable, less allowances of $19 in 2013 and
$31 in 2012 2,559 2,225
Inventories 2,003 2,033
Prepaid expenses and other current assets 220 234
Total current assets 5,184 5,770
Net property, plant and equipment 303 523
Goodwill 486 467
Acquired intangible assets, net 102 218
Other long-term assets 354 23
Total assets $ 6,429 $ 7,001
Liabilities and Stockholders' Equity (Deficit)
Current liabilities:
Revolving credit facility $ 1,127 $ 662
Current portion of long-term debt 265 2,387
Capital lease obligations 10 10
Accounts payable 1,542 2,000
Income taxes payable - -
Accrued expenses 1,296 1,084
Total current liabilities 4,240 6,143
Long-term debt, net of current portion 2,445 -
Long-term portion of capital lease obligations - 10
Other long-term liabilities 178 178
Total liabilities 6,863 6,331
Stockholders' equity (deficit):
Common stock, par value $0.001; shares authorized
150,000,000 at December 31, 2013 and at
December 31, 2012; 83,665,402 shares issued and
outstanding at December 31, 2013 and 76,059,457
at December 31, 20127 84 76
Additional paid-in capital 111,302 110,893
Accumulated deficit (111,674 ) (110,521 )
Accumulated other comprehensive income (146) 222
Total stockholders' equity (deficit) (434) 670
Total liabilities and stockholders' equity $ 6,429 $ 7,001
PROPHOTONIX LIMITED
CONSOLIDATED STATEMENTS OF CASH FLOWS
In thousands
(unaudited)
Years Ended December 31 2013 2012
Operations
Net loss $ (1,153) $ (2,903)
Adjustments to reconcile net loss to net cash used in
operating activities:
Stock-based compensation expense 169 143
Depreciation and amortization 332 396
Foreign exchange (gain) loss (408) (188)
Amortization of debt discount and financing 96 -
costs
Loss on disposal of assets (7) -
Provision for inventories 120 75
Provision for bad debts (12) 25
Other change in assets and liabilities:
Accounts receivable (222) 199
Inventories (8) (372)
Prepaid expenses and other current assets 20 57
Accounts payable (518) 505
Accrued expenses 171 261
Other assets and liabilities (9) 20
Net cash used in operating activities (1,429 ) (1,782 )
Investing
Purchase of property, plant and equipment (17 ) (67 )
Net cash used in investing activities (17 ) (67 )
Financing
Borrowings of revolving credit facilities, net 438 -
Proceeds from issuance of long-term debt 800 -
Principal repayment of long-term debt (339 ) (889 )
Debt issuance costs (398 ) -
Net cash provided by (used in) financing activities 501 (889)
Effect of exchange rate on cash 69 (50)
Net change in cash and equivalents (876) (2,788)
Cash and equivalents at beginning of year 1,278 4,066
Cash and equivalents at end of period $ 402 $ 1,278
Supplemental cash flow information:
Cash paid for interest $ 263 $ 228
Common stock issued in connection with financing $ 193 $ -
Warrants issued in connection with financing $ 55 $ -
PROPHOTONIX LIMITED
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY / (DEFICIT)
(in thousands)
Common Stock
Additional Accumulated Other Total
Par Paid in Accumulated Comprehensive Stockholders'
Shares $0.001 Capital Deficit Income Equity (Deficit)
Balance December 31, 2011
........................... 76,059 $ 76 $ 110,751 $ (107,618) $ 421 $ 3,630
Share based compensation,
net of forfeitures
.................. - - 143 - - 143
Translation adjustment ..... - - - - (199) (199)
Net loss
...........................
. - - - (2,903) - (2,903)
Balance December 31, 2012
........................... 76,059 $ 76 $ 110,893 $ (110,521) $ 222 $ 670
Share based compensation,
net of forfeitures
.................. - - 169 - - 169
Issuance of common stock to
settle liabilities ........ 7,606 8 185 - - 193
Issuance of warrants for
financings
................... - - 55 - - 55
Translation adjustment.... (368) (368)
Net loss
...........................
. - - - (1,153) - (1,153)
Balance December 31, 2013
........................... 83,665 $ 84 $ 111,302 $ (111,674) $ (146) $ (434)
Values may not add due to rounding
Notes to unaudited Preliminary Results
Basis of Presentation
The financial information set out in this document does not
constitute the Company's statutory accounts for 2012 and 2013 or
the Company's annual audited accounts for 2013 to be published and
sent to its shareholders in accordance with Rule 19 of the AIM
Rules for Companies. The 2013 accounts included herein are
unaudited and therefore subject to change at the time the audited
accounts are issued. The 2013 unaudited preliminary financial
statements were prepared under US GAAP and were approved on March
24, 2014, by the Directors for issue on March 25, 2014. It is
intended that the Company's 2013 annual report and audited accounts
will be available to shareholders on or about April 25, 2014.
Cautionary Statement
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. All statements
other than statements of historical fact, including without
limitation, those with respect to ProPhotonix's goals, plans and
strategies set forth herein are forward-looking statements. The
following important factors and uncertainties, among others, could
cause actual results to differ materially from those described in
these forward-looking statements: uncertainty that cash balances
may not be sufficient to allow ProPhotonix to meet all of its
business goals; uncertainty that ProPhotonix's new products will
gain market acceptance; the risk that delays and unanticipated
expenses in developing new products could delay the commercial
release of those products and affect revenue estimates; the risk
that one of our competitors could develop and bring to market a
technology that is superior to those products that we are currently
developing; and ProPhotonix's ability to capitalize on its
significant research and development efforts by successfully
marketing those products that the Company develops. Forward-looking
statements represent management's current expectations and are
inherently uncertain. All Company, brand, and product names are
trademarks or registered trademarks of their respective holders.
ProPhotonix undertakes no duty to update any of these
forward-looking statements.
Use of Non-GAAP Financial Measures
The Company provides non-GAAP financial measures, such as
EBITDA, to complement its consolidated financial statements
presented in accordance with GAAP. Non-GAAP financial measures do
not have any standardized definition and, therefore, are unlikely
to be comparable to similar measures presented by other reporting
companies. These non-GAAP financial measures are intended to
supplement the user's overall understanding of the Company's
current financial and operating performance and its prospects for
the future. Specifically, the Company believes the non-GAAP results
provide useful information to both management and investors by
identifying certain expenses, gains and losses that, when excluded
from the GAAP results, may provide additional understanding of the
Company's core operating results or business performance, which
management uses to evaluate financial performance for purposes of
planning for future periods. However, these non-GAAP financial
measures are not intended to supersede or replace the Company's
GAAP results.
The Company uses EBITDA (earnings before interest, taxes,
depreciation, amortization, and stock-based compensation) as a
non-GAAP financial measure in this press release. A reconciliation
of net loss to EBITDA for the total year 2013 and 2012 is as
follows:
(in thousands)
Year Ended December 31,
2013 2012
------------------------ --------
Net Loss (1,153) (2,903)
Plus:
Interest and other expense / (income), net 45 (233)
Depreciation 212 278
Intangible asset amortization 120 118
Stock based compensation 169 143
Taxes (73) -
------------------------ --------
EBITDA Loss (680) (2,597)
------------------------ --------
Restructuring and nonrecurring charges 582 -
------------------------ --------
Adjusted EBITDA loss (98) (2,597)
------------------------ --------
########
This information is provided by RNS
The company news service from the London Stock Exchange
END
FR QKQDKCBKDDNB
Prophotonix S (LSE:PPIR)
Historical Stock Chart
From May 2024 to Jun 2024
Prophotonix S (LSE:PPIR)
Historical Stock Chart
From Jun 2023 to Jun 2024